Carregant...
Continuous glucose monitoring in youth with cystic fibrosis treated with lumacaftor-ivacaftor
BACKGROUND: The effects of lumacaftor-ivacaftor therapy on glycemia have not been thoroughly investigated. Continuous glucose monitoring (CGM) provides detailed information about glycemic patterns and detects glucose abnormalities earlier than traditional screening tools for diabetes. METHODS: CGM m...
Guardat en:
| Publicat a: | J Cyst Fibros |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6342629/ https://ncbi.nlm.nih.gov/pubmed/30104123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcf.2018.07.010 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|